August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
Discussion and Analysis Quarterly Ending September 30, 2020 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited ( the Company) No. 5
-9320 1 Ref: PCL 2020/018 November 14, 2020 Subject: Management Discussion and Analysis for the 9-month period ended 30 September 2020 To: The President of the Stock Exchange of Thailand Panjawattana
Page 1 No. CMC Sor Lor.012/2019 August 13, 2019 Re: Management Discussion & Analysis for the Period Ended 30 June 2019 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN
The Stock Exchange of Thailand The Meeting of the Board of Directors of KGI Securities (Thailand) Public Company Limited (“the Company”) No. 5/2019, held on 5th November 2019, has approved the reviewed
Discussion and Analysis Quarterly Ending September 30, 2019 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4
MDA Q3_2019 (Eng ) November 8, 2019 Subject : Interim Management Discussion and Analysis of Q3/2019 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
No. ADD 4/2022 23 February 2022 Subject: Management discussion and analysis for the performance of the year 2021 ended 31 December 2021 To: President The Stock Exchange of Thailand AddTech Hub Public
No. ADD 19/2022 11 May 2022 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2022 To: President The Stock Exchange of Thailand AddTech Hub
and price for which conversion can be made shall be clearly provided in the terms and conditions which shall be lower than 50 percent of the issuer's common stock prices prior to or during the offering